BD Completes Acquisition of TriPath Imaging
Expands Presence in Cancer Diagnostics Market
BD (Becton, Dickinson and Company) announced the completion of its acquisition of TriPath Imaging. The acquisition was finalized in accordance with terms originally disclosed in an announcement issued by BD on September 8, 2006.
According to the company, this strategic acquisition aligns innovative new technologies with BD's existing business strategies and is a natural complement to ongoing internal research programs in its BD Diagnostics and BD Biosciences segments. These oncology management tools are intended to span cancer screening, diagnosis, prognosis and therapy monitoring, especially for cancers affecting women's health, including breast, cervical and ovarian.
Most read news
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Anthony_Segal
Serenoa
Allopurinol
5-Azacytidine
Evonik on target after the first half of 2017 - Initial synergies from integration of the Air Products specialty additives business

Singles become pairs: New insights into the light scattering of atoms - Researchers at the Humboldt University of Berlin, partners of the DAALI project, have demonstrated a surprising effect present in the fluorescent light of a single atom
BASF increases prices for ethanolamines in Europe
Removal of carbon dioxide from natural gas: New technology enables energy and cost reduction - Cooperation of JGC , INPEX and BASF successful
Pyrimethamine
